Add-on acquisitions continued to drive financings over buyouts in November, accounting for half the tally, compared to 42% for LBOs, according to Direct Lending Deals. Other proceeds, which include growth financing, accounted for 8% of volume, according to DLD.
Going forward, large-cap issuers are expected to propel M&A volume for direct lenders in 2020 as B-/B3 companies increasingly bypass pushback from CLO investors.
It’s not that CLO managers have suddenly become averse to B-/B3 risk, it’s that their baskets are full. If they are to book new paper at spreads over 100 bps higher than they were a year ago, they need heavy discounting to counter the hit they’ll take unloading lower-priced loans in the secondary to make room for new credits. Two recent executions exemplify this: Syncsort (B-/B3) closed at a discount of 92 and a spread of L+600, while Monotype Imaging (B-/B3) closed at 94 at L+550.
This also leaves the door open for investor-friendly changes to documentation.
In the $10-40M EBITDA band, there is far less volatility because these technical issues simply don’t exist for two main reasons: 1) it’s an illiquid market, and 2) credit funds typically book to hold, and without the pressure of relative value plays and defined rating baskets.
Lenders expect add-on volume to continue apace, while buyouts will be harder to close. Uncertainty is the biggest enemy against buyers and sellers next year. Cyclicals face concerns about the credit cycle’s late stage, while industries affected by tariffs will see more scrutiny, as will healthcare, which will be impacted by who ends up in the White House.
Latest news
US leveraged loans returns turn negative in October
The Bloomberg US Leveraged Loan Index (Ticker: LOAN) has returned -0.26% this month through October 21, reducing its year-to-date return…
M&A activity begins to tick upward
In the third quarter of 2026, acquisition-linked loan volume across North America and Europe reached about $47 billion, up from $30.6 billion in Q2 and $29.5 billion a year ago.
